The crystal structure of Toxoplasma gondii pyruvate kinase 1.
Bakszt, R., Wernimont, A., Allali-Hassani, A., Mok, M.W., Hills, T., Hui, R., Pizarro, J.C.(2010) PLoS One 5: e12736-e12736
- PubMed: 20856875 
- DOI: https://doi.org/10.1371/journal.pone.0012736
- Primary Citation of Related Structures:  
3EOE, 3GG8 - PubMed Abstract: 
Pyruvate kinase (PK), which catalyzes the final step in glycolysis converting phosphoenolpyruvate to pyruvate, is a central metabolic regulator in most organisms. Consequently PK represents an attractive therapeutic target in cancer and human pathogens, like Apicomplexans. The phylum Aplicomplexa, a group of exclusively parasitic organisms, includes the genera Plasmodium, Cryptosporidium and Toxoplasma, the etiological agents of malaria, cryptosporidiosis and toxoplasmosis respectively. Toxoplasma gondii infection causes a mild illness and is a very common infection affecting nearly one third of the world's population.
Organizational Affiliation: 
The Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.